COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
                        
                            
                                申请人:Mitokinin, Inc.
                            
                            
                                公开号:US20200223851A1
                            
                            
                                公开(公告)日:2020-07-16
                            
                            The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease, mitchonodrial disease, fibrosis, and/or cardiomyopathy.